Drug Profile
GSK 870086
Alternative Names: 870086; GSK870086; GW-870086XLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Antiasthmatics
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma; Atopic dermatitis
Most Recent Events
- 04 Aug 2011 GlaxoSmithKline completes a phase II trial in Asthma in Bulgaria, Germany, and South Africa (NCT01245426)
- 19 May 2011 GlaxoSmithKline completes enrolment in its phase II trial for Asthma in Bulgaria, Germany & South Africa (NCT01245426)
- 17 Feb 2011 Phase-II clinical trials in Atopic dermatitis in Germany (Topical)